NEW YORK (GenomeWeb News) – Leica Biosystems today announced it has acquired Kreatech Diagnostics for an undisclosed amount.

Kreatech, based in Amsterdam, is a provider of DNA fluorescent in situ hybridization probes and target labeling reagents for microarrays. It will join Leica's Advanced Staining Business Unit based in Newcastle-upon-Tyne UK.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.